|Salary:||£20,404 to £26,806 per annum (dependent upon experience)|
|Placed On:||23rd August 2019|
|Closes:||26th September 2019|
Fixed Term until 31 March 2022
About the role:
The Clinical and Experimental Pharmacology Group (CEP) aims to enhance clinical trials of new anticancer therapies through biomarker research. An exciting opportunity is available for a Scientific Officer 2 to join the CEP Group and Manchester Centre for Cancer Biomarker Sciences (MCCBS), conducting multidisciplinary translational research, to contribute to their on-going efforts towards personalised medicine for cancer patients.
We are seeking a Scientific Officer 2 to jointly work within our Tissue Biomarkers Team and Tumour Immunology and Inflammation Monitoring Laboratory Team (TIIML) to assist in the development and implementation of tissue biomarkers to monitor immune status and responses. With guidance you will be required to develop and implement biomarker assays on tissue samples from clinical trials under Good Clinical Practice regulations and to develop project management skills in our expanding clinical trials portfolio.
You should have a BSc degree or equivalent in Biological Sciences or related subject (or equivalent relevant experience) and relevant experience with tissue biomarkers. It is desirable that you will possess technical skills in molecular pathology (including but not limited to immunohistochemistry/fluorescence techniques, microscopy, flow cytometry, automated platforms and image analysis) and will be able to communicate effectively and work both independently and within teams.
Previous experience in a Good Clinical Practice (GCP) environment and/or in a clinical setting and knowledge of computer databases in a laboratory setting, e.g. Laboratory Information Management Systems (LIMS) would also be advantageous. Highly desirable is academic training that includes cancer biology.
Why choose Cancer Research UK Manchester Institute?
The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute of The University of Manchester (www.manchester.ac.uk), is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world. We are currently situated at the internationally-renowned life sciences campus at Alderley Park in Cheshire England, 15 miles from Manchester, a vibrant and dynamic city surrounded by beautiful countryside.
We are partnered with The Christie NHS Foundation Trust in South Manchester (www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.
For any informal enquiries about this post, please contact Dr Kathryn Simpson at Kathryn.Simpson@cruk.manchester.ac.uk
To apply for this position please visit our website.
Closing date: at 11:59pm 26 September 2019.
Cancer Research UK Manchester Institute is a Research Institute within The University of Manchester and is core funded by Cancer Research UK
Type / Role: